Vietnam Androgenetic Alopecia Market Size & Outlook
The androgenetic alopecia market in Vietnam is expected to reach a projected revenue of US$ 8.7 million by 2030. A compound annual growth rate of 8.3% is expected of Vietnam androgenetic alopecia market from 2024 to 2030.
The Vietnam androgenetic alopecia market generated a revenue of USD 5.0 million in 2023 and is expected to reach USD 8.7 million by 2030.
The Vietnam market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
In terms of segment, pharmaceuticals was the largest revenue generating treatment in 2023.
Devices is the most lucrative treatment segment registering the fastest growth during the forecast period.
Androgenetic alopecia market data book summary
Market revenue in 2023
USD 5.0 million
Market revenue in 2030
USD 8.7 million
Growth rate
8.3% (CAGR from 2023 to 2030)
Largest segment
Pharmaceuticals
Fastest growing segment
Devices
Historical data
2018 - 2022
Base year
2023
Forecast period
2024 - 2030
Quantitative units
Revenue in USD million
Market segmentation
Pharmaceuticals, Devices
Key market players worldwide
Johnson & Johnson, Cipla Ltd DR, Sun Pharmaceutical Industries, Merck & Co Inc, Dr. Reddy’s Laboratories, Cardiff Lexington Corp, Amgen Inc, Theradome, Aurobindo Pharma, Curallux, Apira Science
Other key industry trends
In terms of revenue, Vietnam accounted for 0.2% of the global androgenetic alopecia market in 2023.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
In Asia Pacific, China androgenetic alopecia market is projected to lead the regional market in terms of revenue in 2030.
India is the fastest growing regional market in Asia Pacific and is projected to reach USD 174.0 million by 2030.
Vietnam’s market is expected to be driven by the increasing incidence of AGA, improving healthcare infrastructure, and rising consumer awareness. In addition, the country’s elderly population is growing at a rapid pace, and this demographic shift is leading to an increased incidence of AGA.
According to the Vietnam Social Security (VSS) data published in October 2022, over 87 million people, which is nearly 88% of total the population, have health insurance, and the government aims to increase the health insurance coverage to 92% of the national population.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Androgenetic Alopecia Market Outlook will help companies and investors design strategic landscapes.
Pharmaceuticals was the largest segment with a revenue share of 98.0% in 2023.
Horizon Databook has segmented the Vietnam androgenetic alopecia market based on pharmaceuticals, devices covering the revenue growth of each sub-segment from 2018 to 2030.
Vietnam’s market is expected to be driven by the increasing incidence of AGA, improving healthcare infrastructure, and rising consumer awareness. In addition, the country’s elderly population is growing at a rapid pace, and this demographic shift is leading to an increased incidence of AGA.
According to the Vietnam Social Security (VSS) data published in October 2022, over 87 million people, which is nearly 88% of total the population, have health insurance, and the government aims to increase the health insurance coverage to 92% of the national population.
Vietnam Androgenetic Alopecia Market Treatment Outlook (Revenue, USD MIllion , 2018-2030)
Pharmaceuticals
Devices
Vietnam Androgenetic Alopecia Market End-use Outlook (Revenue, USD MIllion , 2018-2030)
Homecare Settings
Dermatology Clinics
Vietnam Androgenetic Alopecia Market Sales Channel Outlook (Revenue, USD MIllion , 2018-2030)
Prescriptions
OTC
Vietnam Androgenetic Alopecia Market Gender Outlook (Revenue, USD MIllion , 2018-2030)
Male
Female
Reasons to subscribe to Androgenetic Alopecia Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Androgenetic Alopecia Market Outlook databook
Our clientele includes a mix of Androgenetic Alopecia Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Vietnam Androgenetic Alopecia Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Vietnam Androgenetic Alopecia Market Outlook from 2018 to 2030, including revenue numbers, major trends, and company profiles.